New Jersey Officials Approve Adding Five New Medical Cannabis Conditions

sugar cookie

New Jersey officials have given approval to the addition of five new medical conditions to the state’s medical cannabis program.

sugar cookieNew Jersey’s Medicinal Marijuana Review Panel voted this week to allow the medical use of cannabis for those with migraines, anxiety, Tourette’s syndrome, chronic pain related to musculoskeletal disorders, and chronic pain related to internal organs.

Although the panel was in strong support of allowing individuals with these conditions to become legal medical cannabis patients, State Health Commissioner Cathleen D. Bennett has the final say. She now has up to 180 days to respond; she has the option of approving all five conditions, approving some of the five, or not approving any of them.

Read moreNew Jersey Officials Approve Adding Five New Medical Cannabis Conditions

New Jersey Panel Recommends Adding 43 New Medical Marijuana Conditions

The New Jersey Medicinal Marijuana Review Panel has recommended the state drastically expand their medical marijuana program by adding 43 new conditions that qualify someone to use the medicine.

After months of studying petitions from patients and physicians, and after holding two public hearing, the Medicinal Marijuana Review Panel has recommended adding 43 new medical marijuana conditions, including migraines, anxiety, chronic pain, Alzheimer’s disease, opiate-use disorder, autism and Tourette syndrome. The recommendations, which now must go through several steps to actually become law, would greatly expand one of the nation’s most restrict medical marijuana programs.

The recommendations from the panel will be sent to Health Commissioner Cathleen D. Bennett, who has final say on whether or not the 43 conditions are actually added to the state’s medical marijuana program. There will now be a 60-day public comment period accumulating in a public hearing before Bennett can make her decision.

Read moreNew Jersey Panel Recommends Adding 43 New Medical Marijuana Conditions

New Jersey Officials Vote to Expand Medical Cannabis Program

A New Jersey panel today approved expanding the state’s medical cannabis program by including several new qualifying conditions.

The Medicinal Marijuana Review Panel voted to approve to use of medical cannabis for those with anxiety, irritable bowel syndrome, Tourette syndrome and chronic pain related to muscular skeletal disorders. This would allow those with these conditions to legally purchase, possess and use medical cannabis products, given they receive a recommendation from a physician and register with the state.

Unfortunately the panel voted against recommending medical cannabis for those with asthma and chronic fatigue.

Read moreNew Jersey Officials Vote to Expand Medical Cannabis Program